3: Initial statement of beneficial ownership of securities-Officer Lynn Geoffrey
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
SC 13G: Statement of acquisition of beneficial ownership by individuals-Frank W. Cawood(5.9%)
4: Statement of changes in beneficial ownership of securities-Officer Hooftman Leon
3: Initial statement of beneficial ownership of securities-Officer Hooftman Leon
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wright Robin
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director DAWES KAREN A
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Scheeren Joseph
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Anne M.
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hammacher Alex
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morgon Pierre A.
Barinthus Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-M&G Investment(13.48%),Luxembourg Specialist(10.65%)
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pelletier Nadege
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Griffiths Graham
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Enright William
Barinthus Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Gemma
Vaccitech | 4: Statement of changes in beneficial ownership of securities-Director Scheeren Joseph
Vaccitech | 4: Statement of changes in beneficial ownership of securities-Director Wright Robin
Vaccitech | 4: Statement of changes in beneficial ownership of securities-Director Wright Robin
Vaccitech | 4: Statement of changes in beneficial ownership of securities-Director Scheeren Joseph
No Data